Analystreport

Allogene Therapeutics Inc. (NASDAQ: ALLO) is now covered by analysts at JPMorgan Chase & Co.. They set a "neutral" rating on the stock.

Allogene Therapeutics, Inc.  (ALLO) 
Last allogene therapeutics, inc. earnings: 2/27 04:30 am Check Earnings Report